Shots:
The US FDA has received accelerated approval from the US FDA for Forzinity (elamipretide HCl)] to improve muscle strength in pts with Barth syndrome (Wt.≥30 kg or 66 lbs)
Approval was based on efficacy and safety data from the TAZPOWER trial, which showed improved knee muscle strength
Forzinity is a mitochondrial cardiolipin binder. It…
